These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 2396589

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI, Chung H, Lee J.
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [Abstract] [Full Text] [Related]

  • 7. Fibrous membranes in diabetic retinopathy and bevacizumab.
    Pattwell DM, Stappler T, Sheridan C, Heimann H, Gibran SK, Wong D, Hiscott P.
    Retina; 2010 Dec; 30(7):1012-6. PubMed ID: 20616680
    [Abstract] [Full Text] [Related]

  • 8. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP, Kampik A.
    Fortschr Ophthalmol; 1991 Dec; 88(3):219-24. PubMed ID: 1889766
    [Abstract] [Full Text] [Related]

  • 9. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Dec; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E, Ioachim E, Stefaniotou M, Gorezis S, Charalabopoulos K, Bagli H, Peschos D, Psilas K, Agnantis NJ.
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 14. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I, Omulecki W, Dziegielewski K, Pikulski Z, Omulecka A.
    Klin Oczna; 2006 Jun; 108(1-3):28-31. PubMed ID: 16883935
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M, Esser P, Heimann K, Wiedemann P.
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [Abstract] [Full Text] [Related]

  • 18. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M, Esser P, Wiedemann P, Heimann K.
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [Abstract] [Full Text] [Related]

  • 19. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP, Kampik A.
    Ger J Ophthalmol; 1992 Feb; 1(3-4):170-5. PubMed ID: 1483131
    [Abstract] [Full Text] [Related]

  • 20. [Posterior hyaloid membrane as structural base of growth of neovascular tissue in proliferative diabetic retinopathy].
    Krasnov MM, Sdobnikova SV, Fedorov AA, Stoliarenko GE.
    Vestn Oftalmol; 1998 Feb; 114(3):16-20. PubMed ID: 9720391
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.